α-Glucosyl hesperidin induced an improvement in the bioavailability of pranlukast hemihydrate using high-pressure homogenization

Int J Pharm. 2011 May 30;410(1-2):114-7. doi: 10.1016/j.ijpharm.2011.03.017. Epub 2011 Mar 16.

Abstract

The α-glucosyl hesperidin (Hsp-G)-induced improvement of both the dissolution and absorption properties of pranlukast hemihydrate (PLH) was achieved by means of a high-pressure homogenization (HPH) processing. The average particle size in the HPH-processed suspension was decreased significantly after 50 cycles of processing and reached a constant size of ca. 300 nm. The amount of dissolved PLH gradually increased with the pass number of HPH processing, and was extremely higher than the PLH solubility (0.8 μg/mL at 37°C) after the HPH processing. On a dissolution study of the freeze-dried sample of HPH-processed PLH/Hsp-G (1/10), the apparent solubility of PLH was at least 2.5-fold more than that of untreated PLH crystals. The transport study showed that the amount of PLH that had permeated through the Caco-2 cell monolayers was improved in the case of HPH-processed PLH/Hsp-G (1/10). The bioavailability of PLH from HPH-processed PLH/Hsp-G (1/10) showed a 3.9- and 2.2-fold improvement over the PLH crystal in terms of C(max) and AUC values, respectively. Hsp-G formed an associated structure in aqueous media. High-pressure homogenization provides a good opportunity for molecular-level interaction of PLH and the associated structure of Hsp-G to occur. The use of Hsp-G under HPH processing was a promising way to enhance the dissolution and absorption of PLH without using an organic solvent.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Area Under Curve
  • Biological Availability
  • Biological Transport
  • Caco-2 Cells
  • Chromones / administration & dosage
  • Chromones / pharmacokinetics*
  • Drug Carriers / chemistry*
  • Freeze Drying
  • Glucosides / chemistry*
  • Hesperidin / analogs & derivatives*
  • Hesperidin / chemistry
  • Humans
  • Intestinal Absorption
  • Leukotriene Antagonists / administration & dosage
  • Leukotriene Antagonists / pharmacokinetics*
  • Particle Size
  • Permeability
  • Solubility

Substances

  • Chromones
  • Drug Carriers
  • Glucosides
  • Leukotriene Antagonists
  • glucosyl hesperidin
  • Hesperidin
  • pranlukast